Bafna Pharmaceuticals Ltd.
| BSE: 532989 | Sector: Health care |
| NSE: BAFNAPH | ISIN Code: INE878I01022 |
| BSE 00:00 | 28 Sep | 102.90 |
0.40 (0.39%) |
OPEN
97.90 |
HIGH
102.90 |
LOW
97.85 |
| NSE 00:00 | 28 Sep | 99.10 |
-0.05 (-0.05%) |
OPEN
103.90 |
HIGH
103.90 |
LOW
98.00 |
| OPEN | 97.90 |
| PREVIOUS CLOSE | 102.50 |
| VOLUME | 101 |
| 52-Week high | 190.70 |
| 52-Week low | 97.35 |
| P/E | 37.01 |
| Mkt Cap.(Rs cr) | 243 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bafna Pharmaceuticals Ltd. (BAFNAPH) - Announcements
-
Bafna Pharmaceuticals Ltd Sale Of Equity Shares Of The Company By SRJR Life Science LLP Through Open Market Sale For Minimum P
28/09/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
11/08/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Board Meeting Outcome for .:- Regulation 30 Read With Reg. 33 Of SEBI (Listing Obligations And Discl
11/08/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Board Meeting Intimation for Board Meeting To Consider The Unaudited Results For The Quarter Ended 3
04/08/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report
29/07/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
29/07/2022 | bse
-
Bafna Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM
28/07/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08/07/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
06/07/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Reg. 34 (1) Annual Report.
06/07/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended June 2022
06/07/2022 | bse
-
Bafna Pharmaceuticals Ltd Intimation Of Annual General Meeting And Book Closure Under Regulation 42 Of The Securities And Exch
05/07/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Closure of Trading Window
28/06/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
28/05/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Outcome of Board Meeting (AGM on July 28 2022)
26/05/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th May 2022
26/05/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Inter-Alia Consider And A
20/05/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
09/05/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13/04/2022 | bse |
Downlaod PDF -
Bafna Pharmaceuticals Ltd Certificate From Practicing Company Secretary For The Half Year Ended 31St March 2022
11/04/2022 | bse |
Downlaod PDF
Quick Links for Bafna Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
